Synonym:
(±)-15-Deoxy-(16RS)-16-hydroxy-16-methylprostaglandin E1 methyl ester,
Misoprostol
Properties:
Related Categories |
Analytical Standards,
Analytical/Chromatography,
EP Standards,
EP Standards L - M,
Pharmacopeia & Metrological Institutes Standards
|
Description:
Caution
Please find SDS provided by EDQM here..
General description
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
Other Notes
Sales restrictions may apply.
Packaging
Unit quantity: 5 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference subtance catalogue.
Biochem/physiol Actions
PGE1 analog prodrug which is rapidly de-esterified to active "misoprostolic acid". Cited for extremely wide-ranging therapeutic effects, including prevention of NSAID-induced gastric ulceration, regulation of immunologic cascades, inhibition of platelet-activating factor (PAF), treatment of ethanol- and acetaminophen-induced hepatotoxicity and hepatitis, and stimulation of cartilage repair after injury.
Safety:
Symbol
GHS06, GHS08
Hazard statements
H301-H360
Precautionary statements
Missing Phrase - N15.00950417-P201-P280-P308 + P313
RIDADR
UN 2810 6.1 / PGIII